1. Khamnueva L. Yu., Andreeva L. S., Kosikova I. N. Obesity. Classification, etiology, pathogenesis, clinical picture, diagnosis, treatment: study guide. Irkutsk, Irkutsk State Medical University Publ., 2007. 33 p. (in Russian).
2. Poltorak V. V., Krasova N. S., Gorshunskaya M. Yu. Sirtuins as a promising targets for the prevention and therapy of diabetes mellitus. Problemi endokrynnoi patologii [Problems of endocrine pathology], 2014, no. 3, pp. 97-104 (in Russian).
3. Min Zh., Gao J., Yu Y. The roles of mitochondrial SIRT4 in cellular metabolism. Frontiers in Endocrinology, 2019, vol. 9, art. 783. https://doi.org/10.3389/fendo.2018.00783
4. Loftus T. M., Jaworsky D. E., Frehywot G. L., Townsend C. A., Ronnett G. V., Lane M. D., Kuhajda F. P. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science, 2000, vol. 288, no. 5475, pp. 2379-2381. https://doi.org/10.1126/science.288.5475.2379
5. Kumar M. V., Shimokawa T., Nagy T. R., Lane M. D. Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice. Proceedings of the National Academy of Sciences, 2002, vol. 99, no. 4, pp. 1921-1925. https://doi.org/10.1073/pnas.042683699
6. Mayas M. D., Ortega F. J., Madas-Gonzalez M., Bernal R., Gomez-Huelgas R., Fernandez-Real J. M., Tinahones F. J. Inverse relation between FASN expression in human adipose tissue and the insulin resistance level. Nutrition and Metabolism, 2010, vol. 7, no. 1, pp. 1-7. https://doi.org/10.1186/1743-7075-7-3
7. Schmid B., Rippmann J. F., Tadayyon M., Hamilton B. S. Inhibition of fatty acid synthase prevents preadipocyte differentiation. Biochemical and Biophysical Research Communications, 2005, vol. 328, no. 4, pp. 1073-1082. https://doi.org/10.1016/j.bbrc.2005.01.067
8. Hariri N., Thibault L. High-fat diet-induced obesity in animal models. Nutrition Research Reviews, 2010, vol. 23, no. 2, pp. 270-299. https://doi.org/10.1017/S0954422410000168
9. Kravchuk E. N., Galagudza M. M. Experimental models of metabolic syndrome. Arterial'naya gipertenziya [Arterial hypertension], 2014, vol. 20, no. 5, pp. 377-383 (in Russian).
10. Diaz-Villasenor A. A high fat diet reduces the expression of lipogenic, lipolytic and oxidative genes in white adipose tissue. The effect of the concentration and type of fatty acid is dependent of the dietary protein. FASEB Journal, 2010, vol. 24, p. 938.11. https://doi.org/10.1096/fasebj.24.1_supplement.938.11
11. Eissing L., Scherer T., Todter K., Knippschild U., Greve J. W., Buurman W. A. [et al.] De novo lipogenesis in human fat and liver is linked to ChREBP-band metabolic health. Nature Communications, 2013, vol. 4, no. 1, pp. 1-11. https://doi.org/10.1038/ncomms2537
12. Berndt J., Kovacs P., Ruschke K., Kloting N., Fasshauer M., Schon M. R., Korner A., Stumvoll M., Bluher M. Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia, 2007, vol. 50, no. 7, pp. 1472-1480. https://doi.org/10.1007/s00125-007-0689-x
13. Moreno-Indias I., Tinahones F. J. Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders. Journal of Diabetes Research, 2015, vol. 2015, art. 970375. https://doi.org/10.1155/2015/970375
14. Tkachuk V. A., Vorotnikov A. V. Molecular mechanisms of development of insulin resistance. Sakharnyi diabet [Diabetes mellitus], 2014, no. 2, pp. 29-40 (in Russian).
15. Zaganjor E., Vyas S., Haigis M. C. SIRT4 is a regulator of insulin secretion. Cell Chemical Biology, 2017, vol. 24, no. 6, pp. 656-658. https://doi.org/10.1016/j.chembiol.2017.06.002
16. Lopaschuk G. D. Fatty acid oxidation and its relation with insulin resistance and associated disorders. Annals of Nutrition and Metabolism, 2016, vol. 68, suppl. 3, pp. 15-20. https://doi.org/10.1159/000448357
17. Fernandez-Real J. M., Menendez J. A., Moreno-Navarrete J. M., Bluher M., Vazquez-Martin A., Vazquez M., Ortega J. F., Dieguez C., Fruhbeck G., Ricart W., Vidal-Puig A. Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance. Diabetes, 2010, vol. 59, no. 6, pp. 1506-1511. https://doi.org/10.2337/db09-1756
18. Abdulkadirova F. R., Ametov A. S., Doskina E. V., Pokrovskaya R. A. The role of lipotoxicity in the pathogenesis of type 2 diabetes mellitus and obesity. Ozhireniye i metabolizm [Obesity and metabolism], 2014, vol. 11, no. 2, pp. 8-12 (in Russian).